Genomma Lab Internacional, S.A.B. de C.V. (FRA:GEKA)

Market Cap	793.58M -29.7%
Revenue (ttm)	845.22M +4.1%
Net Income	79.69M +7.0%
EPS	0.08 +0.9%
Shares Out	n/a
PE Ratio	9.96
Forward PE	7.31
Dividend	0.04 (4.60%)
Ex-Dividend Date	Dec 22, 2025

Volume	n/a
Average Volume	283
Open	0.8000
Previous Close	0.8000
Day's Range	0.8000 - 0.8000
52-Week Range	0.7700 - 1.3500
Beta	n/a
RSI	31.86
Earnings Date	Feb 25, 2026

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 1,708
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GEKA

Financial Performance

In 2024, Genomma Lab Internacional's revenue was 18.61 billion, an increase of 12.99% compared to the previous year's 16.47 billion. Earnings were 2.09 billion, an increase of 92.74%.

Financial numbers in MXN